192 related articles for article (PubMed ID: 18216468)
1. Risk factors and treatment at recurrent stroke onset: results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study.
Leoo T; Lindgren A; Petersson J; von Arbin M
Cerebrovasc Dis; 2008; 25(3):254-60. PubMed ID: 18216468
[TBL] [Abstract][Full Text] [Related]
2. Which risk factors are more associated with ischemic stroke than intracerebral hemorrhage in patients with atrial fibrillation?
McGrath ER; Kapral MK; Fang J; Eikelboom JW; ó Conghaile A; Canavan M; O'Donnell MJ;
Stroke; 2012 Aug; 43(8):2048-54. PubMed ID: 22618379
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study.
Yaghi S; Mistry E; Liberman AL; Giles J; Asad SD; Liu A; Nagy M; Kaushal A; Azher I; Mac Grory B; Fakhri H; Brown Espaillat K; Pasupuleti H; Martin H; Tan J; Veerasamy M; Esenwa C; Cheng N; Moncrieffe K; Moeini-Naghani I; Siddu M; Scher E; Trivedi T; Lord A; Furie K; Keyrouz S; Nouh A; Leon Guerrero CR; de Havenon A; Khan M; Henninger N
Stroke; 2020 Sep; 51(9):2724-2732. PubMed ID: 32757753
[TBL] [Abstract][Full Text] [Related]
4. Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study.
Paciaroni M; Agnelli G; Falocci N; Caso V; Becattini C; Marcheselli S; Rueckert C; Pezzini A; Poli L; Padovani A; Csiba L; Szabó L; Sohn SI; Tassinari T; Abdul-Rahim AH; Michel P; Cordier M; Vanacker P; Remillard S; Alberti A; Venti M; Scoditti U; Denti L; Orlandi G; Chiti A; Gialdini G; Bovi P; Carletti M; Rigatelli A; Putaala J; Tatlisumak T; Masotti L; Lorenzini G; Tassi R; Guideri F; Martini G; Tsivgoulis G; Vadikolias K; Liantinioti C; Corea F; Del Sette M; Ageno W; De Lodovici ML; Bono G; Baldi A; D'Anna S; Sacco S; Carolei A; Tiseo C; Acciarresi M; D'Amore C; Imberti D; Zabzuni D; Doronin B; Volodina V; Consoli D; Galati F; Pieroni A; Toni D; Monaco S; Baronello MM; Barlinn K; Pallesen LP; Kepplinger J; Bodechtel U; Gerber J; Deleu D; Melikyan G; Ibrahim F; Akhtar N; Mosconi MG; Bubba V; Silvestri I; Lees KR
Stroke; 2015 Aug; 46(8):2175-82. PubMed ID: 26130094
[TBL] [Abstract][Full Text] [Related]
5. Recurrence after ischemic stroke in chinese patients: impact of uncontrolled modifiable risk factors.
Xu G; Liu X; Wu W; Zhang R; Yin Q
Cerebrovasc Dis; 2007; 23(2-3):117-20. PubMed ID: 17124391
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and treatment of stroke at the time of recurrence.
Laloux P; Lemonnier F; Jamart J
Acta Neurol Belg; 2010 Dec; 110(4):299-302. PubMed ID: 21305857
[TBL] [Abstract][Full Text] [Related]
7. Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial.
Åsberg S; Hijazi Z; Norrving B; Terént A; Öhagen P; Oldgren J
Trials; 2017 Dec; 18(1):581. PubMed ID: 29197413
[TBL] [Abstract][Full Text] [Related]
8. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
O'Donnell MJ; Chin SL; Rangarajan S; Xavier D; Liu L; Zhang H; Rao-Melacini P; Zhang X; Pais P; Agapay S; Lopez-Jaramillo P; Damasceno A; Langhorne P; McQueen MJ; Rosengren A; Dehghan M; Hankey GJ; Dans AL; Elsayed A; Avezum A; Mondo C; Diener HC; Ryglewicz D; Czlonkowska A; Pogosova N; Weimar C; Iqbal R; Diaz R; Yusoff K; Yusufali A; Oguz A; Wang X; Penaherrera E; Lanas F; Ogah OS; Ogunniyi A; Iversen HK; Malaga G; Rumboldt Z; Oveisgharan S; Al Hussain F; Magazi D; Nilanont Y; Ferguson J; Pare G; Yusuf S;
Lancet; 2016 Aug; 388(10046):761-75. PubMed ID: 27431356
[TBL] [Abstract][Full Text] [Related]
9. Evaluation on the compliance with secondary prevention and influence factors of ischemic stroke in Hainan province, China.
Su Q; Yuan K; Long F; Wan Z; Li C; Cai Y; Zeng C; Wu Y; Wu H; Liu S; Li P; Zhou J; Chen C; Wang D; Yan L; Zhang Y; Dai M
Vascular; 2014 Jun; 22(3):181-7. PubMed ID: 23929417
[TBL] [Abstract][Full Text] [Related]
10. Prevention of ischemic stroke: overview of traditional risk factors.
Romero JR
Curr Drug Targets; 2007 Jul; 8(7):794-801. PubMed ID: 17630932
[TBL] [Abstract][Full Text] [Related]
11. Disparities in Antihypertensive Prescribing After Stroke: Linked Data From the Australian Stroke Clinical Registry.
Dalli LL; Kim J; Thrift AG; Andrew NE; Lannin NA; Anderson CS; Grimley R; Katzenellenbogen JM; Boyd J; Lindley RI; Pollack M; Jude M; Durairaj R; Shah D; Cadilhac DA; Kilkenny MF
Stroke; 2019 Dec; 50(12):3592-3599. PubMed ID: 31648630
[TBL] [Abstract][Full Text] [Related]
12. An approach of patients with ischemic stroke to primary and secondary stroke prevention in Poland.
Nowacki P; Porebska A; Bajer-Czajkowska A; Zywica A; Koziarska D; Podbielski J
Ann Acad Med Stetin; 2007; 53(2):14-9. PubMed ID: 18557372
[TBL] [Abstract][Full Text] [Related]
13. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?
Johnson P; Rosewell M; James MA
Cerebrovasc Dis; 2007; 23(2-3):156-61. PubMed ID: 17124397
[TBL] [Abstract][Full Text] [Related]
14. Non-vitamin K oral anticoagulants as first-line regimen for acute ischemic stroke with non-valvular atrial fibrillation.
Park CW; Nam HS; Heo JH; Park HJ; Choi JK; Lee HS; Na HK; Kim YD
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105025. PubMed ID: 32807440
[TBL] [Abstract][Full Text] [Related]
15. Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke.
Jung YH; Kim YD; Kim J; Han SW; Oh MS; Lee JS; Lee KY
Stroke; 2020 Sep; 51(9):2733-2741. PubMed ID: 32811392
[TBL] [Abstract][Full Text] [Related]
16. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
17. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
Trials; 2015 Sep; 16():393. PubMed ID: 26340977
[TBL] [Abstract][Full Text] [Related]
18. To Treat or Not to Treat: Anticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation.
Appelros P; Farahmand B; Terént A; Åsberg S
Stroke; 2017 Jun; 48(6):1617-1623. PubMed ID: 28487335
[TBL] [Abstract][Full Text] [Related]
19. Ischemic stroke in patients receiving aspirin.
Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
[TBL] [Abstract][Full Text] [Related]
20. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke.
Rothwell PM; Algra A; Amarenco P
Lancet; 2011 May; 377(9778):1681-92. PubMed ID: 21571151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
